Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference
Top Cited Papers
- 30 June 2007
- journal article
- review article
- Published by Elsevier BV in Leukemia Research
- Vol. 31 (6), 727-736
- https://doi.org/10.1016/j.leukres.2006.11.009
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- The myelodysplastic syndromes: Diagnosis, molecular biology and risk assessmentHematology, 2005
- A Comparative Review of Classification Systems in Myelodysplastic Syndromes (MDS)Seminars in Oncology, 2005
- Additional Prognostic Value of Bone Marrow Histology in Patients Subclassified According to the International Prognostic Scoring System for Myelodysplastic SyndromesJournal of Clinical Oncology, 2003
- CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameterfor the diagnosis and classification of myelodysplastic syndromesEuropean Journal of Haematology, 2000
- Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromesBritish Journal of Haematology, 1996
- QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.Journal of Clinical Pathology, 1995
- Myelodysplastic Syndrome Associated with Bone Marrow FibrosisLeukemia & Lymphoma, 1992
- Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.Journal of Clinical Pathology, 1991
- Bone marrow histology in myelodysplastic syndromesBritish Journal of Haematology, 1984
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982